Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.430
+0.080 (5.93%)
At close: Apr 17, 2025, 4:00 PM
1.490
+0.060 (4.20%)
After-hours: Apr 17, 2025, 5:54 PM EDT
Autolus Therapeutics Employees
As of December 31, 2024, Autolus Therapeutics had 650 total employees, including 647 full-time and 3 part-time employees. The number of employees increased by 179 or 38.00% compared to the previous year.
Employees
650
Change (1Y)
179
Growth (1Y)
38.00%
Revenue / Employee
$15,569
Profits / Employee
-$339,480
Market Cap
380.56M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
AUTL News
- 16 days ago - Autolus Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 17 days ago - Autolus Therapeutics to Host R&D Investor Event on Wednesday, April 23, 2025 - GlobeNewsWire
- 4 weeks ago - Autolus Therapeutics plc (AUTL) Q4 2024 Earnings Conference Call Transcript - Seeking Alpha
- 4 weeks ago - Autolus Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates - GlobeNewsWire
- 6 weeks ago - Autolus Therapeutics to Report Fourth Quarter 2024 Financial Results and Host Conference Call on March 20, 2025 - GlobeNewsWire
- 6 weeks ago - Autolus Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - Autolus Therapeutics: Beaten Down, Cash Rich, Poised To Launch A CAR-T Cell Therapy - Seeking Alpha
- 3 months ago - Autolus Therapeutics Presents Clinical Data Updates at the 2025 Tandem Meetings - GlobeNewsWire